19687-04-8

Basic information

• Product Name: 2-(1-methylcyclopropyl)ethanol
• CAS NO: 19687-04-8
• Molecular Formula: C₆H₁₂O
• Molecular Weight: 100.1589
• Mol File: 19687-04-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 129.4°C at 760 mmHg
• Flash Point: 41.1°C
• Density: 0.938g/cm³
• Vapor Pressure: 4.59mmHg at 25°C
• Refractive Index: 1.461
• CAS DataBase Reference: 2-(1-methylcyclopropyl)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1-methylcyclopropyl)ethanol(19687-04-8)
• EPA Substance Registry System: 2-(1-methylcyclopropyl)ethanol(19687-04-8)

Safety Data

• Hazardous Substances Data: 19687-04-8(Hazardous Substances Data)

Usage

General Description

2-(1-methylcyclopropyl)ethanol, also known as methylcyclopropylethyl alcohol, is a chemical compound with the molecular formula C6H12O. It is a colorless liquid with a slightly sweet odor, and is commonly used as a solvent and intermediate in the production of other chemicals. It is also used as a flavoring agent in the food industry. 2-(1-methylcyclopropyl)ethanol is flammable and may cause irritation to the skin, eyes, and respiratory system upon exposure. It is important to handle and store this chemical with care and in accordance with safety regulations.

Upstream product

• 763-32-6 2-methyl-1-buten-4-ol 
• 75-11-6 diiodomethane 
• 14399-53-2 bis(iodomethyl)zinc 
• 593-71-5 Chloroiodomethane 
• 16906-27-7 1-methyl-1-vinyl-cyclopropane 

Downstream Products

• 63064-32-4 2-(1-methylcyclopropyl)ethyl 4-methylbenzenesulfonate 

Relevant articles and documents

B(C6F5)3-Catalyzed Ring Opening and Isomerization of Unactivated Cyclopropanes

Catalytic amounts of B(C6F5)3 promote the ring opening and subsequent isomerization of a series of unactivated cyclopropanes to afford terminal olefins in good yields when a hydrosilane and 2,6-dibromopyridine are employed as additives.

PIPERIDINE-DIONE DERIVATIVES

The invention provides novel compounds having the general formula (I) and tautomers and pharmaceutically acceptable salts thereof, wherein A1, A2, A3, A4, R1, R4, R5, R6, R7 and R8 are as defined herein, compositions including the compounds and methods of using the compounds.

Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same

The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (GRLN, growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and/or variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as antagonists or inverse agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, obesity and obesity-associated disorders, appetite or eating disorders, addictive disorders, cardiovascular disorders, gastrointestinal disorders, genetic disorders, hyperproliferative disorders, central nervous system disorders and inflammatory disorders.